Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16001171 | 0.90 | GABRA1 (0.46) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL11674273 | 0.88 | GABRA1 (0.44) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL70083 | 0.85 | CYP3A4 (0.42) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL26506104 | 0.83 | HSD17B10 (0.44) | GABRA1GABRB2CYP3A4PTPN1PTPN11 | |
| SCHEMBL18747583 | 0.82 | SHBG (0.41) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL11296783 | 0.82 | PTPN1 (0.42) | GABRA1GABRB2CYP3A4PTPN1PTPN11 | |
| SCHEMBL5023947 | 0.82 | GABRA1 (0.55) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL11678468 | 0.81 | ALOX5 (0.45) | GABRA1GABRB2CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL11675083 | 0.81 | TAAR1 (0.49) | CYP1A2CYP2C9ALOX15ALOX12 | |
| SCHEMBL10870742 | 0.80 | CA12 (0.41) | GABRA1GABRB2CYP3A4PTPN1PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115427514-B | Resin composition, light-shielding film, and substrate with partition wall | 东丽株式会社 | 2024-01-02 | — | — | CN | claimed |
| US-8846982-B2 | Process for the preparation of hydroquinones | MERCK PATENT GMBH (DE) | 2014-09-30 | — | — | US | claimed |
| EP-2558433-B1 | PROCESS FOR THE PREPARATION OF HYDROQUINONES | MERCK PATENT GMBH (DE) | 2014-06-18 | — | — | EP | claimed |
| US-20130211149-A1 | Process for the preparation of hydroquinones | MERCK PATENT GMBH (DE) | 2013-08-15 | — | — | US | claimed |
| EP-2558433-A1 | PROCESS FOR THE PREPARATION OF HYDROQUINONES | Merck Patent GmbH (DE) | 2013-02-20 | — | — | EP | claimed |
| WO-2011128018-A1 | PROCESS FOR THE PREPARATION OF HYDROQUINONES | MERCK PATENT GMBH (DE) | 2011-10-20 | — | — | WO | claimed |
| CN-118511126-A | Resin composition, light-shielding film, method for producing light-shielding film, substrate with partition wall, and display device | 东丽株式会社 | 2024-08-16 | — | — | CN | disclosed |
| CN-115427514-B | Resin composition, light-shielding film, and substrate with partition wall | 东丽株式会社 | 2024-01-02 | — | — | CN | disclosed |
| WO-2023157713-A1 | RESIN COMPOSITION, LIGHT-BLOCKING FILM, METHOD FOR PRODUCING LIGHT-BLOCKING FILM, SUBSTRATE HAVING PARTITIONING WALL ATTACHED THERETO, AND DISPLAY DEVICE | 東レ株式会社 | 2023-08-24 | — | — | WO | disclosed |
| CN-113056524-B | Coloring composition | 住友化学株式会社 | 2023-08-04 | — | — | CN | disclosed |
| CN-115427514-A | Resin composition, light-shielding film and substrate with partition wall | 东丽株式会社 | 2022-12-02 | — | — | CN | disclosed |
| CN-113056524-A | Coloring composition | 住友化学株式会社 | 2021-06-29 | — | — | CN | disclosed |
| CN-112996860-A | Coloring composition | 住友化学株式会社 | 2021-06-18 | — | — | CN | disclosed |
| EP-1836183-A2 | SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS | Galileo Pharmaceuticals, Inc. (US) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006065686-A2 | SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS | GALILEO PHARMACEUTICALS, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| US-20060128790-A1 | Spiro derivatives as lipoxygenase inhibitors | GALILEO PHARMACEUTICALS, INC. | 2006-06-15 | — | — | US | disclosed |
| US-4424381-A | COMPLEXING WITH GROUP 2A METAL HALIDE | KOPPERS COMPANY, INC. (US) | 1984-01-03 | — | — | US | disclosed |
| EP-0048878-A1 | Phosphorous-acid esters containing hydroxyphenyl groups, process for their preparation and their use as stabilisers for thermoplastic polyesters | BAYER AG (DE) | 1982-04-07 | — | — | EP | disclosed |
| US-4296231-A | CONTAINING A HYDROXY AND ETHER-CONTAINING AMINE COMPOUND AS A CURING CATALYST | CIBA-GEIGY CORPORATION (US) | 1981-10-20 | — | — | US | disclosed |
| US-4182918-A | Process for the preparation of polyhydric phenols | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130211149-A1 | Process for the preparation of hydroquinones | NQO1, TTPA, TMT1A | GABRA1 2825/4885GABRB2 2668/4885CYP3A4 462/4885 |
| US-20060128790-A1 | Spiro derivatives as lipoxygenase inhibitors | ALOX15B, ALOX5, ALOX15 | GABRA1 3804/4885GABRB2 3651/4885CYP3A4 317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.